stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Operating cash flow
ICON PLC's operating cash flow for fiscal 2025 was $1.0B, down 19.5% from $1.3B in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.0B. Over the past ten years it has ranged from $259.2M (fiscal 2016) to $1.3B (fiscal 2024); the current reading is higher than 82% of that period. ICON PLC ranks 9th of 49 Diagnostics & Research companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.0B | (19.47%) |
| FY2024 | $1.3B | 10.82% |
| FY2023 | $1.2B | 106.11% |
| FY2022 | $563.3M | (32.06%) |
| FY2021 | $829.1M | 45.97% |
| FY2020 | $568.0M | 37.69% |
| FY2019 | $412.5M | 53.57% |
| FY2018 | $268.6M | (29.87%) |
| FY2017 | $383.1M | 47.79% |
| FY2016 | $259.2M | (7.12%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $345.1M | 22.71% |
| Jun 2026 | $281.3M | 68.42% |
| Mar 2026 | $167.0M | (28.68%) |
| Dec 2025 | $234.2M | (39.59%) |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $2.0B |
| LH Labcorp Holdings Inc. compare | $1.8B |
| ILMN Illumina, Inc. compare | $1.2B |
| ICLR ICON PLC | $1.0B |
| MEDP Medpace Holdings, Inc. compare | $723.0M |
| RVTY Revvity Inc. compare | $655.8M |
| QGEN QIAGEN N.V. compare | $654.5M |
| CRL Charles River Laboratories International, Inc. compare | $622.4M |
| GH Guardant Health, Inc. compare | −$173.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement